Abstract
Tricyclic antidepressants remain a common cause of fatal drug poisoning as a result of their cardiovascular toxicity manifested by ECG abnormalities, arrhythmias and hypotension. Dosulepin and amitriptyline appear to be particularly toxic in overdose. The principal mechanism of toxicity is cardiac sodium channel blockade, which increases the duration of the cardiac action potential and refractory period and delays atrioventricular conduction. Electrocardiographic changes include prolongation of the PR, QRS and QT intervals, nonspecific ST segment and T wave changes, atrioventricular block, right axis deviation of the terminal 40ms vector of the QRS complex in the frontal plane (T 40ms axis) and the Brugada pattern (downsloping ST segment elevation in leads V1–V3 in association with right bundle branch block). Maximal changes in the QRS duration and the T 40ms axis are usually present within 12 hours of ingestion but may take up to a week to resolve. Sinus tachycardia is the most common arrhythmia due to anticholinergic activity and inhibition of norepinephrine uptake by tricyclic antidepressants but bradyarrhythmias (due to atrioventricular block) and tachyarrhythmias (supraventricular and ventricular) may occur. Torsade de pointes occurs uncommonly. Hypotension results from a combination of reduced myocardial contractility and reduced systemic vascular resistance due to α-adrenergic blockade. Life-threatening arrhythmias and death due to tricyclic antidepressant poisoning usually occurs within 24 hours of ingestion. Rapid deterioration is common. Level of consciousness at presentation is the most sensitive clinical predictor of serious complications. Although a QRS duration >100ms and a rightward T 40ms axis appear to be better predictors of cardiovascular toxicity than the plasma tricyclic drug concentration, they have at best moderate sensitivity and specificity for predicting complications.
Similar content being viewed by others
References
Bradberry SM, Thanacoody HKR, Watt BE, et al. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate. Toxicol Rev 2005; 24(3): 195–204
Thomas SHL, Bevan L, Bhattacharyya S, et al. Presentation of poisoned patients to accident and emergency departments in the North of England. Hum Exp Toxicol 1996; 15: 466–70
Buckley NA, Whyte IM, Dawson AH, et al. Self-poisoning in Newcastle, 1987–1992. Med J Aust 1995; 162: 190–3
Obafunwa JO, Busuttil A. Deaths from substance overdose in the Lothian and Borders region of Scotland (1983–1991). Hum Exp Toxicol 1994; 13: 401–6
Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221–4
Shah R, Uren Z, Baker A, et al. Deaths from antidepressants in England and Wales 1993–1997: analysis of a new national database. Psychol Med 2001; 31: 1203–10
Glauser J. Tricyclic antidepressant poisoning. Cleve Clin J Med 2000; 67: 704–19
Buckley NA, Dawson AH, Whyte IM, et al. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet 1994; 343: 159–62
Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Q J Med 2003; 96: 369–74
Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002; 325: 1332–3
Dziukas LJ, Vohra J. Tricyclic antidepressant poisoning. Med J Aust 1991; 154: 344–50
Hurst HE, Jarboe CH. Clinical findings, elimination pharmacokinetics, and tissue drug concentrations following a fatal amitriptyline intoxication. J Toxicol Clin Toxicol 1981; 18: 119–25
Spiker DG, Biggs JT. Tricyclic antidepressants: prolonged plasma levels after overdose. JAMA 1976; 236: 1711–2
Vohra J, Burrows G, Hunt D, et al. The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol 1975; 3: 219–27
Teschemacher AG, Seward EP, Hancox JC, et al. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br J Pharmacol 1999; 128: 479–85
Brennan FJ. Electrophysiologic effects of imipramine and doxepin on normal and depressed cardiac Purkinje fibers. Am J Cardiol 1980; 46: 599–606
Steeds RP, Muthusamy R. Abnormal ventricular conduction following dothiepin overdose simulating acute myocardial infarction. Heart 2000; 83: 289
Zakynthinos E, Vassilakopoulos T, Roussos C, et al. Abnormal atrial and ventricular repolarisation resembling myocardial injury after tricyclic antidepressant drug intoxication. Heart 2000; 83: 353–4
Krayenbuehl P-A, Christen S. Tricyclic antidepressant overdose mimicking myocardial infarction. J Clin Basic Cardiol 2002; 5: 197
Chamsi-Pasha H, Barnes PC. Myocardial infarction: a complication of amitriptyline overdose. Postgrad Med J 1988; 64: 968–70
Arya B, Hirudayaraj P, Willmer K. Myocardial infarction: a rare complication of dothiepin overdose. Int J Cardiol 2004; 96: 493–4
Frommer DA, Kulig KW, Marx JA, et al. Tricyclic antidepressant overdose: a review. JAMA 1987; 257: 521–6
Langou RA, Van Dyke C, Tahan SR, et al. Cardiovascular manifestations of tricyclic antidepressant overdose. Am Heart J 1980; 100: 458–64
Pellinen TJ, Farkkila M, Heikkila J, et al. Electrocardiographic and clinical features of tricyclic antidepressant intoxication. Ann Clin Res 1987; 19: 12–7
Goldberg RJ, Capone RJ, Hunt JD. Cardiac complications following tricyclic antidepressant overdose: issues for monitoring policy. JAMA 1985; 254: 1772–5
Niemann JT, Bessen HA, Rothstein RJ, et al. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 1986; 57: 1154–9
Wolfe TR, Caravati EM, Rollins DE. Terminal 40-ms frontal plane QRS axis as a marker for tricyclic antidepressant overdose. Ann Emerg Med 1989; 18: 348–51
Lavoie FW, Gansert GG, Weiss RE. Value of initial ECG findings and plasma drug levels in cyclic antidepressant overdose. Ann Emerg Med 1990; 19: 696–700
Chow BJ, Gollob M, Birnie D. Brugada syndrome precipitated by a tricyclic antidepressant. Heart 2005; 91: 651
Babaliaros VC, Hurst JW. Tricyclic antidepressants and the Brugada syndrome: an example of Brugada waves appearing after the administration of desipramine. Clin Cardiol 2002; 25: 395–8
Bolognesi R, Tsialtas D, Vasini P, et al. Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose. Am J Cardiol 1997; 79: 242–5
Tada H, Sticherling C, Oral H, et al. Brugada syndrome mimicked by tricyclic antidepressant overdose. J Cardiovasc Electrophysiol 2001; 12: 275
Bigwood B, Galler D, Amir N, et al. Brugada syndrome following tricyclic antidepressant overdose. Anaesth Intensive Care 2005; 33: 266–70
Goldgran-Toledano D, Sideris G, Kevorkian J-P. Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 2002; 346: 1591–2
Liebelt EL, Ulrich A, Francis PD, et al. Serial electrocardiogram changes in acute tricyclic antidepressant overdoses. Crit Care Med 1997; 25: 1721–6
Shannon MW. Duration of QRS disturbances after severe tricyclic antidepressant intoxication. J Toxicol Clin Toxicol 1992; 30: 377–86
Noble J, Matthew H. Acute poisoning by tricyclic antidepressants: clinical features and management of 100 patients. J Toxicol Clin Toxicol 1969; 2: 403–21
Bramble MG, Lishman AH, Purdon J, et al. An analysis of plasma levels and 24-hour ECG recordings in tricyclic antidepressant poisoning: implications for management. Q J Med 1985; 56: 357–66
Fasoli RA, Glauser FL. Cardiac arrhythmias and ECG abnormalities in tricyclic antidepressant overdose. J Toxicol Clin Toxicol 1981; 18: 155–63
Thorstrand C. Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG. Acta Med Scand 1976; 199: 337–44
Callaham M, Kassel D. Epidemiology of fatal tricyclic antidepressant ingestion: implications for management. Ann Emerg Med 1985; 14: 1–9
Alter P, Tontsch D, Grimm W. Doxepin-induced torsade de pointes tachycardia. Ann Intern Med 2001; 135: 384–5
Davison ET. Amitriptyline-induced torsade de pointes: successful therapy with atrial pacing. J Electrocardiol 1985; 18: 299–301
Crome P, Newman B. Fatal tricyclic antidepressant poisoning. J R Soc Med 1979; 72: 649–53
Hulten BA, Heath A. Clinical aspects of tricyclic antidepressant poisoning. Acta Med Scand 1983; 213: 275–8
Pentel P, Sioris L. Incidence of late arrhythmias following tricyclic antidepressant overdose. J Toxicol Clin Toxicol 1981; 18: 543–8
Desager JP, Leonard JP, Vanderbist M, et al. Reduced cardiac output and renal blood flow during amitriptyline intoxication in conscious rabbits. Toxicol Appl Pharmacol 1979; 47: 445–9
Heard K, Cain BS, Dart RC, et al. Tricyclic antidepressants directly depress human myocardial mechanical function independent of effects on the conduction system. Acad Emerg Med 2001; 8: 1122–7
Shannon M, Merola J, Lovejoy Jr FH. Hypotension in severe tricyclic antidepressant overdose. Am J Emerg Med 1988; 6: 439–42
Foulke GE, Albertson TE, Walby WF. Tricyclic antidepressant overdose: emergency department findings as predictors of clinical course. Am J Emerg Med 1986; 4: 496–500
Emerman CL, Connors Jr AF, Burma GM. Level of consciousness as a predictor of complications following tricyclic overdose. Ann Emerg Med 1987; 16: 326–30
Matthew H, Lawson AAH. Acute barbiturate poisoning: a review of two years experience. Q J Med 1966; 35: 539–52
Hultén B-Å, Adams R, Askenasi R, et al. Predicting severity of tricyclic antidepressant overdose. J Toxicol Clin Toxicol 1992; 30: 161–70
Foulke GE. Identifying toxicity risk early after antidepressant overdose. Am J Emerg Med 1995; 13: 123–6
Caravati EM, Bossart PJ. Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. J Toxicol Clin Toxicol 1991; 29: 31–43
Ellison DW, Pentel PR. Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med 1989; 7: 5–10
Lipper B, Bell A, Gaynor B. Recurrent hypotension immediately after seizures in nortriptyline overdose. Am J Emerg Med 1994; 12: 452–3
Taboulet P, Michard F, Muszynski J, et al. Cardiovascular repercussions of seizures during cyclic antidepressant poisoning. J Toxicol Clin Toxicol 1995; 33: 205–11
Boehnert MT, Lovejoy Jr FH. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985; 313: 474–9
Foulke GE, Albertson TE. QRS interval in tricyclic antidepressant overdosage inaccuracy as a toxicity indicator in emergency settings. Ann Emerg Med 1987; 16: 160–3
Buckley NA, O’Connell DL, Whyte IM, et al. Interrater agreement in the measurement of QRS interval in tricyclic antidepressant overdose: implications for monitoring and research. Ann Emerg Med 1996; 28: 515–9
Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med 1995; 26: 195–201
Buckley NA, Chevalier S, Leditschke IA, et al. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose. Crit Care 2003; 7: R101–7
Petit JM, Spiker DG, Ruwitch JF, et al. Tricyclic antidepressant plasma levels and adverse effects after overdose. Clin Pharmacol Ther 1977; 21: 47–51
Spiker DG, Weiss AN, Chang SS, et al. Tricyclic antidepressant overdose: clinical presentation and plasma levels. Clin Pharmacol Ther 1975; 18: 539–46
Hanzlick RL. Postmortem blood concentrations of parent tricyclic antidepressant (TCA) drugs in 11 cases of suicide. Am J Forensic Med Pathol 1984; 5: 11–3
Rudorfer MV. Cardiovascular changes and plasma drug levels after amitriptyline overdose. J Toxicol Clin Toxicol 1982; 19: 67–78
Marshall JB. Tricyclic overdose. JAMA 1980; 244: 1900
Amitai Y, Erickson T, Kennedy EJ, et al. Tricyclic antidepressants in red cells and plasma: correlation with impaired intraventricular conduction in acute overdose. Clin Pharmacol Ther 1993; 54: 219–27
Bailey B, Buckley NA, Amre DK. A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose. J Toxicol Clin Toxicol 2004; 42: 877–88
Callaham M. Admission criteria for tricyclic antidepressant ingestion. West J Med 1982; 137: 425–9
Sedal L, Korman MG, Williams PO, et al. Overdosage of tricyclic antidepressants: a report of two deaths and a prospective study of 24 patients. Med J Aust 1972; 2: 74–9
Masters AB. Delayed death in imipramine poisoning. BMJ 1967; 3: 866–7
McAlpine SB, Calabro JJ, Robinson MD, et al. Late death in tricyclic antidepressant overdose revisited. Ann Emerg Med 1986; 15: 1349–52
Bloodworth L, Wilson A, Collins P, et al. Severe dothiepin intoxication: a report of two cases. Postgrad Med J 1984; 60: 442–4
Babb SV, Dunlop SR. Case report of sudden and unexpected death after tricyclic overdose. Am J Psychiatry 1985; 142: 275–6
Chiu TF, Yang CC, Ger J, et al. Adult respiratory distress syndrome and late death following imipramine overdose: a case report. Chin Med J 1994; 54: 436–41
Acknowledgements
No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thanacoody, H.K.R., Thomas, S.H.L. Tricyclic Antidepressant Poisoning. Toxicol Rev 24, 205–214 (2005). https://doi.org/10.2165/00139709-200524030-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00139709-200524030-00013